Please login to the form below

Not currently logged in
Email:
Password:

Porter Novelli announces new senior health role

New senior VP Amy Nicole Nayar has experience at Pfizer
amy-nicole-nayar-porter-novelli

Porter Novelli has created a new senior VP of global health and wellness role in order to strengthen firm's 'commitment to client value'.

Amy Nicole Nayar, veteran of pharma company Pfizer, is the first person to be appointed to the position and will lead key healthcare client engagements. She will report to Henry Engleka, who is also senior VP of global health and wellness.

Before joining Porter Novelli, Nayar ran Forefront Leadership – an organisational change and leadership skills firm. Her clients include forms from the media, retail, life science, finance and technology sectors.

Previously she spent 14 years at Pfizer, running teams within the corporate affairs, marketing and medical functions. Nayar ended her time with Pfizer as head of strategy and capability development for international public affairs under policy, external affairs and communications.

"Amy Nicole is not only a published health economic outcomes researcher, she's also a well-regarded leader effective at managing and motivating external-facing teams to do exceptional work," said Darlan Monterisi, managing director, Porter Novelli New York.

Nayar said she was thrilled to have the opportunity to work with Porter Novelli's 'highly engaged and collaborative teams'.

24th July 2014

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Consulting at McCann Health

We are the strategic consultancy of McCann Health. We combine fresh and creative thinking with scientific and strategic depth...

Latest intelligence

BRIC markets
BRIC markets
Why these countries offer an opportunity for pharma despite a slowdown...
Obstetrics Virtual Journal Club: An Impetus Digital Customer Success Story
Our online solutions are not just for advisory boards - find out how one client leveraged the Impetus InSite Platform® for a virtual journal club....
Ludovic Helfgott
Novo Nordisk awakens its ‘Sleeping Beauty’
Biopharm emerges from troubled times to hit ‘solid growth’, says executive vice president Ludovic Helfgott...

Infographics